Importantly, the differential Kla sites showed a more discrete pattern in the distinct subtypes, with 27 sites identified only in liver cancer, 37 in pancreatic cancer, 548 in colorectal cancer, and 69 in gastric cancer (Figure 5C; Table S6A, Supporting Information). This evidence concerns the gene KL and familial pancreatic carcinoma.